In models of bony metastases, stromal chemokines were able to induce AKT signalling in PCa cells and thus generate an osteolytic reaction in vivo that worsened tumour burden, perhaps by liberating immunomodulatory factors contained within the bone. The gene discussed is AKT1; the disease is posterior cortical atrophy.